Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors.
about
Current management and future directions in the treatment of advanced renal cell carcinoma-a latin american perspective: 10 years in reviewHeme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib.Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials.
P2860
Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prognostic biomarkers for pati ...... ed tyrosine kinase inhibitors.
@en
type
label
Prognostic biomarkers for pati ...... ed tyrosine kinase inhibitors.
@en
prefLabel
Prognostic biomarkers for pati ...... ed tyrosine kinase inhibitors.
@en
P2860
P356
P1476
Prognostic biomarkers for pati ...... ed tyrosine kinase inhibitors.
@en
P2093
Daniel C Cho
P2860
P304
P356
10.2147/OTT.S45872
P407
P577
2013-06-13T00:00:00Z